跳至主要内容
临床试验/EUCTR2005-003669-18-DE
EUCTR2005-003669-18-DE进行中(未招募)不适用

Efficacy an tolerability of a combinatzion of glucosamine sulphate and the tw omega-3 unsaturated fatty acids EPA and DHA in comparison to glucosamine sulphate in patients with ostearthritis

Seven Seas Limited0 个研究点目标入组 182 人开始时间: 2006年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
182

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age: 40 - 75 years (contraception of women of childbearing age)
  • - Currently untreated osteoarthritic complaints with moderate to severe pain (WOMAC pain score = 300 - 400 mm)
  • - Functional disability of the hip or knee joint
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Severe organ and systemic diseases, particularly those which reduce liver and kidney function or gastrointestinal diseases
  • - Treatment with steroidal or non-steroidal antirheumatics
  • - Use of dietary supplements which contain omega-3 fatty acids (e. g. fish oil), gammalinolenic acid (e. g. evening primrose oil, borage seed oil), glucosamine (glucosamine sulphate or glucosamine hydrochloride) and/or chondroitin

研究者

发起方
Seven Seas Limited

相似试验